Clarity Wealth Advisors, LLC Amgen Inc Transaction History

Clarity Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $916 - $1,164	-4 Reduced 0.42%	945 $248,000
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $3,142 - $3,544	-14 Reduced 1.45%	949 $213,000
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $1,153 - $1,283	-5 Reduced 0.52%	963 $234,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $1,096 - $1,212	-5 Reduced 0.51%	968 $234,000
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $198 - $227	-1 Reduced 0.1%	973 $218,000
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $2,334 - $2,735	-11 Reduced 1.12%	974 $207,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $3,503 - $3,887	15 Added 1.55%	985 $240,000
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $215,252 - $250,842	970 New	970 $241,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Clarity Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarity Wealth Advisors, LLC with notifications on news.